Probing the dynamics of prion diseases with amphotericin B

Trends in Microbiology

Volumn 5, Issue 1, 1997, Pages 27-31

  Adjou, Karim Tarik ^a   Deslys, Jean Philippe ^a   Demaimay, Rémi ^a   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

CENTRAL NERVOUS SYSTEM; DRUG EFFECT; GENE EXPRESSION; HAMSTER; MOUSE; NERVE DEGENERATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SCRAPIE;

CRICETINAE;

EID: 0031039648     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(97)81771-4     Document Type: Review

References (31)

1. Büeler, H. et al. (1992) Nature 356, 577-582
2. Prusiner, S.B. (1993) Philos. Trans. R. Soc. London Ser. B 339, 239-254
3. Sakaguchi, S. et al. (1996) Nature 380, 528-531
4. Tobler, I. et al. (1996) Nature 380, 639-642
5. DeArmond, S.J. and Prusiner, S.B. (1995) Am. J. Pathol. 146, 785-811
6. Bruce, M.E., Mcbride, P.A. and Farquhar, C.F. (1989) Neurosci. Lett. 102, 1-6
7. Forloni, G. et al. (1993) Nature 362, 543-546
8. Forloni, G. et al. (1994) Eur. J. Neurosci. 6, 1415-1422
9. Prusiner, S.B. (1982) Science 216, 136-144
10. Prusiner, S.B. (1993) Arch. Neurol. 50, 1129-1153
11. Amyx, H. et al. (1984) Neurology 34, 149
12. Pocchiari, M. et al. (1989) in Unconventional Virus Diseases of the Central Nervous System (Court, L.A. et al., eds), pp. 314-323, Commissariat à l'Energie Atomique (CEA) Diffusion
13. Pocchiari, M., Schmitinger, S. and Masulo, C. (1987) J. Gen. Virol. 68, 219-223
14. Brown, P. (1990) Antiviral Chem. Chemother. 1, 75-83
15. Xi, Y.G. et al. (1992) Nature 356, 598-601
16. McKenzie, D. et al. (1994) J. Virol. 68, 7534-7536
17. Saint Julien, L. et al. (1992) Antimicrob. Agents Chemother. 36, 2722-2728
18. Demaimay, R. et al. (1994) J. Gen. Virol. 75, 2499-2503
19. Adjou, K.T. et al. (1995) Antimicrob. Agents Chemother. 39, 2810-2812
20. Adjou, K.T. et al. (1996) Res. Virol. 147, 213-218
21. Kimberlin, R.H. and Walker, C.A. (1977) J. Gen. Virol. 34, 295-304
22. Lasmézas, C.I. et al. (1996) J. Gen. Virol. 77, 1601-1609
23. Medoff, G. et al. (1983) Annu. Rev. Pharmacol. Toxicol. 23, 303-330
24. Bowler, W.A. and Oldfield, E.C. (1992) Infect. Med. 9, 17-23
25. Szoka, F.C. and Tang, M. (1993) J. Liposome Res. 3, 363-375
26. Palacios, J. and Serrano, R. (1978) FEBS Lett. 91, 198-201
27. Vertut-Doï, A., Ohnishi, S. and Bolard, J. (1994) Antimicrob. Agents Chemother. 38, 2373-2379
28. Carp, R.I. (1992) in Neuropathogenic Viruses and Immunity (Specter, S. et al., eds), pp. 111-136, Plenum Press
29. Taraboulos, A. et al. (1995) J. Cell Biol. 129, 121-132
30. Shyng, S.L. et al. (1995) J. Biol. Chem. 270, 14793-14800
31. Telling, G.C. et al. (1995) Cell 83, 79-90